Human Infections with Thymine-Requiring Bacteria

References

1. Andrew M. H. E. 1973; Use of trimethoprim to obtain thymine-requiring mutants of Streptococcus faecalis. J. gen. Microbiol 74:195
   [Google Scholar]
2. Arlinger L. 1971; Isotachophoresis in capillary tubes. Protides biol. Fluids 19:513
   [Google Scholar]
3. Bailey R. R., Roberts A. R., Gower P. E., de Wardener H. E. 1971; Prevention of urinary-tract infection with low-dose nitrofurantoin. Lancet 2:1112
   [Google Scholar]
4. Barker J., Healing D., Hutchison J. G. P. 1972; Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients. J. clin. Path 25:1086
   [Google Scholar]
5. Barner H. D., Cohen S. S. 1959; Virus-induced acquisition of metabolic function. IV. Thymidilate synthetase in thymine-requiring Escherichia coli infected by T2 and T5 bacteriophages. J. biol. Chem 234:2987
   [Google Scholar]
6. Cattell W. R., Chamberlain D. A., Fry I. K., McSherry M. A., Broughton C., O’Grady F. 1971; Long-term control of bacteriuria with trimethoprim-sulphonamide. Br. med. J 1:377
   [Google Scholar]
7. Cleaver J. E. 1967; Thymidine metabolism and cell kinetics. Frontiers of biology series edited by Neuberger A., Tatum E. L. vol 6: Amsterdam: p 60
   [Google Scholar]
8. Clowes R. C., Hayes W. 1968 Experiments in microbial genetics Oxford:
   [Google Scholar]
9. Cowan S. T., Steel K. J. 1966 Manual for the identification of medical bacteria London:
   [Google Scholar]
10. Everaerts F. M., Becker J. L. 1976 Isotachophoresis: theory, instrumentation and applications Amsterdam:
    [Google Scholar]
11. Hayek L. J., Netherway J. 1976; Thymine-requiring bacteria. Lancet 1:1080
    [Google Scholar]
12. Hoffee P. A., Robertson B. C. 1969; 2-Deoxyribose gene-enzyme complex in Salmonella typhimurium: regulation of phospho-deoxyribomutase. J. Bact 97:1386
    [Google Scholar]
13. Jaffe J. J., McCormack J. J., Meymarian E. 1972; Comparative properties of schistosomal and filarial dihydrofolate reductases. Biochem. Pharmac 21:719
    [Google Scholar]
14. Lacey R. W., Lewis E. L. 1973; Is co-trimoxazole bactericidal in sputum?. Br. med. J 4:165
    [Google Scholar]
15. Lowbury E. J. L., Kidson A., Lilly H. A. 1964; A new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci. J. clin. Path 17:231
    [Google Scholar]
16. Mackey J. P., Sandys G. H. 1966; Diagnosis of urinary infections; clinical aspects. Br. med. J 1:1173
    [Google Scholar]
17. Maskell R., Okubadejo O. A., Payne R. H. 1976; Thymine-requiring bacteria associated with co-trimoxazole therapy. Lancet 1:834
    [Google Scholar]
18. Okubadejo O. A., Maskell R. M. 1973; Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo. J. gen. Microbiol 77:533
    [Google Scholar]
19. Sandys G. H. 1960; A new method of preventing swarming of Proteus spp. with a description of a new medium suitable for use in routine laboratory practice. J. med. Lab. Technol 17:224
    [Google Scholar]
20. Smellie J. M., Gruneberg R. N., Leakey A., Atkin W. S. 1976; Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infections: clinical aspects. Br. med. J 2:203
    [Google Scholar]
21. Stacey K. A., Simson E. 1965; Improved method for the isolation of thymine-requiring mutants of Escherichia coli. J. Bact 90:554
    [Google Scholar]
22. Tanner E. I., Bullin C. H. 1974; Thymidine-dependent Escherichia coli infection and some associated laboratory problems. J. clin. Path 27:565
    [Google Scholar]
23. Tapsall J. W., Wilson E., Harper J. 1974; Thymine dependent strains of Escherichia coli selected by trimethoprim-sulphamethoxazole therapy. Pathology 6:161
    [Google Scholar]
24. Then R., Angehrn P. 1974; Co-trimoxazole resistance. Br. med. J 1:78
    [Google Scholar]